"Radiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
| Descriptor ID |
D018714
|
| MeSH Number(s) |
E02.186.775 E02.815.600
|
| Concept/Terms |
Radiotherapy, Adjuvant- Radiotherapy, Adjuvant
- Adjuvant Radiotherapy
- Adjuvant Radiotherapies
- Radiotherapies, Adjuvant
|
Below are MeSH descriptors whose meaning is more general than "Radiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Radiotherapy, Adjuvant".
This graph shows the total number of publications written about "Radiotherapy, Adjuvant" by people in this website by year, and whether "Radiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 5 | 5 |
| 1996 | 0 | 4 | 4 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 6 | 6 |
| 2000 | 0 | 7 | 7 |
| 2001 | 3 | 7 | 10 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 7 | 8 |
| 2004 | 1 | 10 | 11 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 7 | 7 |
| 2007 | 0 | 11 | 11 |
| 2008 | 2 | 11 | 13 |
| 2009 | 2 | 10 | 12 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 9 | 9 |
| 2012 | 0 | 7 | 7 |
| 2013 | 0 | 10 | 10 |
| 2014 | 1 | 5 | 6 |
| 2015 | 2 | 8 | 10 |
| 2016 | 3 | 7 | 10 |
| 2017 | 3 | 9 | 12 |
| 2018 | 0 | 7 | 7 |
| 2019 | 3 | 4 | 7 |
| 2020 | 1 | 2 | 3 |
| 2021 | 0 | 7 | 7 |
| 2022 | 0 | 4 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiotherapy, Adjuvant" by people in Profiles.
-
Treatment Outcomes of Patients with Ependymoma Receiving Radiotherapy: A Single Institution Experience. Oncology. 2024; 102(11):913-923.
-
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). J Clin Oncol. 2023 06 10; 41(17):3184-3193.
-
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study. Gynecol Oncol. 2022 Dec; 167(3):452-457.
-
An Updated Review on Radiation Treatment Management in Thymus Cancers. Clin Lung Cancer. 2022 11; 23(7):561-570.
-
Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival. Int J Gynecol Cancer. 2022 07 04; 32(7):869-874.
-
Surgical Issues for Operable Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2022 02 20; 40(6):530-538.
-
ASO Visual Abstract: The Impact of Radiotherapy Delay in Breast-Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Ann Surg Oncol. 2021 12; 28(Suppl 3):572-573.
-
Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer. Surgery. 2022 01; 171(1):197-202.
-
Hypofractionated Radiation Therapy for Breast Cancer: Financial Risk and Expenditures in the United States, 2008 to 2017. Int J Radiat Oncol Biol Phys. 2022 03 01; 112(3):654-662.
-
Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm. Surgery. 2022 01; 171(1):203-211.